Jin Xu

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

Arjun Vasant Balar, Daniel Castellano, Petros Grivas et al. · Annals of Oncology · 2022 · 114 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and Older

Boris Kerzner, Alexander V. Murray, Rudy Ifle et al. · Journal of the American Geriatrics Society · 2007 · 96 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old

C. Raina MacIntyre, Tony Egerton, Malcolm McCaughey et al. · Human Vaccines · 2010 · 72 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and Immunogenicity of a Combination: Measles, Mumps, Rubella and Varicella Vaccine (ProQuad®)

Barbara J. Kuter, Michelle Brown, Jonathan Hartzel et al. · Human Vaccines · 2006 · 55 citations

Veterinary Medicine, Immunology, Pediatrics +17

Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial.

Joaquim Bellmunt, Andrea Necchi, Ronald de Wit et al. · Journal of Clinical Oncology · 2021 · 55 citations

Medicine, Oncology, Pharmacotherapy +16